CD272 (BTLA) Antibody, anti-mouse, PE-Vio® 770, REAfinity™ 130-102-687 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD272 (BTLA) Antibody, anti-mouse, PE-Vio® 770, REAfinity™

Miltenyi Biotec's CD272 (BTLA) Antibody, anti-mouse, PE-Vio® 770, REAfinity™ is a Human monoclonal antibody. The CD272 (BTLA) Antibody, anti-mouse, PE-Vio® 770, REAfinity™ was generated using BTLA as the antigen. It reacts with Mouse. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD272 (BTLA) Antibody, anti-mouse, PE-Vio® 770, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-102-687
Quantity30 µg in 1 mL
ApplicationsFlow cytometry
Conjugate/TagPE-Vio 770
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivitymouse
TargetCD272 (BTLA)
IsotypeIgG1
CloneREA224
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene NameB and T lymphocyte associated
NCBI Gene AliasesA630002H24
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:10
ModificationsRecombinantly engineered
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cellsProceedings of the National Academy of Sciences of the United States of AmericaMarch 26, 2013Kobayashi Y, Iwata A, Suzuki K, Suto A, Kawashima S, Saito Y, Owada T, Kobayashi M, Watanabe N, Nakajima H.

(2) Slow down and survive: Enigmatic immunoregulation by BTLA and HVEMAnnual review of immunologyJanuary 1, 2010Murphy TL, Murphy KM.

(3) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature immunologyJuly 1, 2003Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, et al.

Be the First to Write a Review!